Skip to main content
7May

Predictive AI in Healthcare: Lessons From the Front Line

Hosted by the Department of Statistics and the Department of Health Policy
LSE, Thai theatre, 54 Lincoln's Inn Fields, London WC2A 3LJ
Thursday 7 May 2026 5.30pm - 7pm

Medicine shortages are not accidents — they are predictable. So why do they keep catching us off guard?

Join us for the first event in our new In-Practice public lecture series, bringing together leading practitioners to explore how cutting-edge research translates into real-world impact.

This evening focuses on the pharmaceutical supply chain and the growing role of predictive artificial intelligence in detecting medicine shortages before they reach patients. Drawing on large-scale health data, regulatory signals, and supply chain intelligence, our speakers will examine the early warning signs of drug disruption — and what it takes to act on them in time.

With deployments already live across UK and international healthcare systems, this is not a theoretical discussion. It is a window into what AI-driven tools look like in practice, and what they mean for the future of medicines access and health system resilience.

Speakers:

  • Akber Tahir - CEO and Founder, Pharmovo AI · LSE Generate Startup of the Year 2025

Akber Tahir is the Founder and CEO of Pharmovo AI, a company building predictive intelligence for pharmaceutical supply chains. Pharmovo began before his degree of BSc Management at LSE, in 2020. Akber scaled and raised funding for Pharmovo during his undergraduate studies and today works with governments, healthcare providers, pharmaceutical manufacturers, and distributors, to deploy frontier machine-learning to solve healthcares toughest problems. Pharmovo uses machine learning to identify medicine shortages weeks before they occur by combining demand data, regulatory signals, and upstream manufacturing dependencies into a unified model. His work focuses on moving healthcare systems from reactive crisis management to proactive intervention, enabling providers, manufacturers, and governments to anticipate disruption and protect patient access to critical medicines.

  • Dr Sara Geneletti - Associate Professor and MSc Health Data Science Programme Director

LSE holds a wide range of events, covering many of the most controversial issues of the day, and speakers at our events may express views that cause offence. The views expressed by speakers at LSE events do not reflect the position or views of the London School of Economics and Political Science.